ELRANATAMAB

Clinical trials for ELRANATAMAB explained in plain language.

Never miss a new study

Get alerted when new ELRANATAMAB trials appear

Sign up with your email to follow new studies for ELRANATAMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

New hope for chinese patients with stubborn myeloma: experimental drug shows promise

Disease control Completed

This study tested a new medicine, elranatamab, in 39 Chinese adults with multiple myeloma that stopped responding to several standard treatments. The drug works by helping the body's immune system attack the cancer cells. The goal was to see if the drug is safe and can shrink or …

Matched conditions: ELRANATAMAB

Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control

Last updated May 13, 2026 16:02 UTC

ELRANATAMAB

Get alerted when new ELRANATAMAB trials appear

New hope for chinese patients with stubborn myeloma: experimental drug shows promise